{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:16:13Z","timestamp":1792095373121,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1993,10,1]],"date-time":"1993-10-01T00:00:00Z","timestamp":749433600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[1993,10]]},"DOI":"10.1007\/bf01320914","type":"journal-article","created":{"date-parts":[[2005,3,27]],"date-time":"2005-03-27T00:28:15Z","timestamp":1111883295000},"page":"278-282","source":"Crossref","is-referenced-by-count":37,"title":["The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats"],"prefix":"10.1007","volume":"53","author":[{"given":"Michiko","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Markatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Gregory","family":"Seedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Masarachia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon A.","family":"Rodan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Balena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2165\/00003495-199142060-00003","volume":"42","author":"H Fleisch","year":"1991","unstructured":"Fleisch H (1991) Bisphosphonates: pharmacology and use in the treatment of tumor-induced hypercalcemia and metastatic bone disease. Drugs 42:919?944","journal-title":"Drugs"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2165\/00003495-199040060-00005","volume":"40","author":"DJ Hosking","year":"1990","unstructured":"Hosking DJ (1990) Advances in the management of Paget's disease of bone. Drugs 40:829?840","journal-title":"Drugs"},{"key":"CR3","first-page":"S63","volume":"8","author":"P Minaire","year":"1987","unstructured":"Minaire P, Depassio J, Bernard E, Meunier PJ, Edouard C, Pilonchery G, Goedert G (1987) Effects of clodronate on immobilization bone loss. Bone 8:S63-S68","journal-title":"Bone"},{"key":"CR4","first-page":"841","volume":"13","author":"SE Papapoloulos","year":"1992","unstructured":"Papapoloulos SE, Landman JO, Bijvoet OLM, Lowik CWGM, Valkema R, Pauwels EKJ, Vermeij P (1992) The use of bisphosphonates in the treatment of osteoporosis. Bone 13:841?849","journal-title":"Bone"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/BF02405086","volume":"35","author":"RR Martodam","year":"1983","unstructured":"Martodam RR, Thornton KS, Sica DA, D'Souza SM, Flora L, Mundy GR (1983) The effects of dichloromethylene diphosphonate on hypercalcemia and other parameters of humoral hypercalcemia of malignancy in the rat Leydig cell tumor. Calcif Tissue Int 35:512?519","journal-title":"Calcif Tissue Int"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/1097-0142(19850301)55:5<1030::AID-CNCR2820550518>3.0.CO;2-Y","volume":"55","author":"J Radl","year":"1985","unstructured":"Radl J, Corese JW, Zurcher C, van den Enden-Vieveen MH, Brondijk RJ (1985) Influence of treatment with APDbisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma. Cancer 55:1030?1040","journal-title":"Cancer"},{"key":"CR7","first-page":"6193","volume":"47","author":"ST Kozak","year":"1987","unstructured":"Kozak ST, Rizzoli R, Trechsel U, Fleisch H (1987) Effect of a single injection of two new bisphosphonates on the hypercalcemia and hypercalciuria induced by Walker carcinosarcoma 256\/B in thyroparathyroidectomized rats. Cancer Res 47:6193?6197","journal-title":"Cancer Res"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jbmr.5650050312","volume":"5","author":"DD Thompson","year":"1990","unstructured":"Thompson DD, Seedor JG, Weinreb M, Rosini S, Rodan GA (1990) Aminohydroxybutane bisphosphonate inhibits bone loss due to immobilization in rats. J Bone Miner Res 5:279?286","journal-title":"J Bone Miner Res"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/jbmr.5650060405","volume":"6","author":"JG Seedor","year":"1991","unstructured":"Seedor JG, Quartuccio H, Thompson DD (1991) The bisphosphonate alendronate inhibits bone loss due to ovariectomy in rats. J Bone Miner Res 6:339?346","journal-title":"J Bone Miner Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/jbmr.5650070812","volume":"7","author":"DD Thompson","year":"1992","unstructured":"Thompson DD, Seedor JG, Quartuccio H, Solomon H, Fiolavanti C, Davidson J, Klein H, Clair J, Frankenfield D, Brown E, Simmons HA, Rodan GA (1992) The bisphosphonate, alendronate, prevents bone loss in ovariectomized baboons. J Bone Miner Res 7:951?960","journal-title":"J Bone Miner Res"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0030-5898(20)30490-9","volume":"3","author":"PJ Meunier","year":"1972","unstructured":"Meunier PJ, Bianchi GGS, Edouard CM, Bernard JC, Courpron P, Vignon GE (1972) Bony manifestations of thyrotoxicosis. Orthop Clin North Am 3:745?774","journal-title":"Orthop Clin North Am"},{"key":"CR12","first-page":"113","volume":"6","author":"HM Perry III","year":"1989","unstructured":"Perry HM III (1989) Thyroid hormones and mineral metabolism. Bone Miner Res 6:113?137","journal-title":"Bone Miner Res"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0889-8529(18)30338-4","volume":"19","author":"L Mosekilde","year":"1990","unstructured":"Mosekilde L, Eriksen EF, Charles P (1990) Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 19:35?63","journal-title":"Endocrinol Metab Clin North Am"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/1043-2760(92)90098-L","volume":"3","author":"JA Franklyn","year":"1992","unstructured":"Franklyn JA, Sheppard MC (1992) The thyroid and osteoporosis. Trends Endocrinol Metab 3:113?116","journal-title":"Trends Endocrinol Metab"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/archinte.1985.00360050147025","volume":"145","author":"SH Toh","year":"1985","unstructured":"Toh SH, Claunch BC, Brown PH (1985) Effect of hyperthyroidism and its treatment on bone mineral content. Arch Intern Med 145:883?886","journal-title":"Arch Intern Med"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/jbmr.5650071015","volume":"7","author":"B Ongphiphadhanakul","year":"1992","unstructured":"Ongphiphadhanakul B, Alex S, Braverman LE, Baron DT (1992) Excessive L-thyroxine therapy decreases femoral bone mineral densities in the male rat: effect of hypogonadism and calcitonin. J Bone Miner Res 7:1227?1231","journal-title":"J Bone Miner Res"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/BF02555748","volume":"38","author":"R Schenk","year":"1986","unstructured":"Schenk R, Eggli P, Fleisch H, Rosini S (1986) Quantitative morphometric evaluation of the inhibitory activity of new aminobisphosphonates on bone resorption in the rat. Calcif Tissue Int 38:342?349","journal-title":"Calcif Tissue Int"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595?610","journal-title":"J Bone Miner Res"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ar.1092080114","volume":"208","author":"R Baron","year":"1984","unstructured":"Baron R, Tross R, Vignery A (1984) Evidence of sequential remodeling in rat trabecular bone: morphology, dynamic histomorphometry, and changes during skeletal maturation. Anatom Rec 208:137?145","journal-title":"Anatom Rec"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0169-6009(92)90809-R","volume":"18","author":"HM Frost","year":"1992","unstructured":"Frost HM, Jee WSS (1992) On the rat model of human osteopenias and osteoporoses. Bone Miner 18:227?236","journal-title":"Bone Miner"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3181\/00379727-120-30432","volume":"120","author":"JA Friedland","year":"1965","unstructured":"Friedland JA, Williams GA, Bowser EN, Henderson WJ, Hoffeins E (1965) Effect of hyperthyroidism on intestinal absorption of calcium in the rat. Proc Soc Exp Biol Med 120:20?23","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/BF02409469","volume":"33","author":"Y Weisman","year":"1981","unstructured":"Weisman Y, Eisenberg Z, Lubelski R, Spirer Z, Edelstein S, Harell A (1981) Decreased 1,25-dihydroxycholecalciferol and increased 25-hydroxy- and 24,25-dihydroxycholecalciferol in tissues of rats treated with thyroxine. Calcif Tissue Int 33:445?447","journal-title":"Calcif Tissue Int"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1210\/endo-72-3-382","volume":"72","author":"RI Gregerman","year":"1963","unstructured":"Gregerman RI (1963) Estimation of thyroxine secretion rate in the rat by the radioactive thyroxine turnover technique: influence of age, sex and exposure to cold. Endocrinology 72:382?392","journal-title":"Endocrinology"},{"key":"CR24","first-page":"141","volume":"85","author":"F Melsen","year":"1977","unstructured":"Melsen F, Mosekilde L (1977) Morphometric and dynamic studies of bone changes in hyperthyroidism. Acta Pathol Microbiol Scand [A] 85:141?150","journal-title":"Acta Pathol Microbiol Scand [A]"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1001\/archinte.1983.00350030052010","volume":"143","author":"MD Fallon","year":"1983","unstructured":"Fallon MD, Perry HM III, Bergfeld M, Droke D, Teitelbaum SL, Avioli LV (1983) Exogenous hyperthyroidism with osteoporosis. Arch Intern Med 143:442?444","journal-title":"Arch Intern Med"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archinte.1986.00360130058007","volume":"146","author":"JM Coindre","year":"1986","unstructured":"Coindre JM, David J-P, Reviere L, Goussot JF, Roger P, de Mascarel A (1986) Bone loss in hypothyroidism with hormonal replacement: a histomorphometric study. Arch Intern Med 146:48?53","journal-title":"Arch Intern Med"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/8756-3282(85)90218-2","volume":"6","author":"EF Eriksen","year":"1985","unstructured":"Eriksen EF, Mosekilde L, Melsen F (1985) Trabecular bone remodeling and bone balance in hyperthyroidism. Bone 6:421?428","journal-title":"Bone"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1210\/jcem-62-5-1056","volume":"62","author":"BP Lukert","year":"1986","unstructured":"Lukert BP, Higgins JC, Stoskopf MM (1986) Serum osteocalcin is increased in patients with hyperthyroidism and decreased in patients receiving glucocorticoids. J Clin Endocrinol Metab 62:1056?1058","journal-title":"J Clin Endocrinol Metab"},{"key":"CR29","first-page":"926","volume":"19","author":"JH Lin","year":"1991","unstructured":"Lin JH, Duggan DE, Chen I-W, Ellsworth RL (1991) Physiological disposition of alendronate, a potent anti-osteolitic bisphosphonate, in laboratory animals. Drug Metab Dispos 19:926?932","journal-title":"Drug Metab Dispos"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01320914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01320914\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01320914","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T13:27:39Z","timestamp":1625664459000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01320914"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1993,10]]}},"alternative-id":["BF01320914"],"URL":"https:\/\/doi.org\/10.1007\/bf01320914","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,10]]}}}